Schellenberg Wittmer acted as counsel to Rapid Nutrition PLC, a natural healthcare company, in the listing of its shares at the SIX Swiss Exchange. This is the first English company to have a primary listing of its shares on the SIX Swiss Exchange.
The Schellenberg Wittmer team included Martin Lanz (Partner – Banking and Finance) and Cornelia Jurt (Associate – Banking & Finance).
Delphi has assisted Rejlers when they conducted a rights issue for which the subscription period ended on March 31, 2017. Rejlers will receive proceeds amounting to approximately SEK 200 million.
Rejlers is one of the largest engineering consultancy firms in the Nordic region with 2,000 experts work with projects in the areas of Building and property, Energy, Industry and Infrastructure. Rejlers can be found in 80 locations in Sweden, Finland and Norway. Rejlers recorded revenue of SEK 2.3 billion in 2016 and its class B share is listed on Nasdaq Stockholm.
Hong Kong- Paul Hastings, a leading global law firm, announced today that the firm advised CIMB Investment Bank, Maybank Investment Bank, Hong Leong Investment Bank and UOB Kay Hian Securities as the joint bookrunners of Eco World International Berhad’s (“Eco World International”) US$580 million initial public offering and listing on the Main Market of Bursa Malaysia. Eco World International develops real estate properties in the United Kingdom and Australia. This marks the largest Malaysian IPO so far in 2017.
Setterwalls has advised Arise AB (publ) in connection with a rights issue of convertible bonds with preferential rights for existing shareholders of SEK 245 million.
The convertible bonds are traded on Nasdaq Stockholm and can be converted into new ordinary shares in Arise at a conversion price of SEK 22. The convertible bonds will run until March 31, 2022 with a coupon rate of 5.75 per cent.
Vinge has advised Ambea AB (publ) (“Ambea”) in connection with its listing on Nasdaq Stockholm. The prospectus was published on 20 March 2017 and the first day of trading on Nasdaq Stockholm was 31 March 2017. The price in the offering was SEK 75 per share, corresponding to a market value of Ambea of approximately SEK 5 billion.
Baker McKenzie recently acted for Bell Potter, in its role as sole lead manager and underwriter to Mesoblast Limited's fully underwritten institutional placement, which raised approximately $52.5 million. The proceeds from the placement will be used by Mesoblast for its ongoing Phase 3 clinical programs including chronic heart failure, as well as for manufacturing requirements associated with product commercialisation.
Mesoblast is a world leader in delivering innovative cell-based medicines and is dual-listed on the ASX and Nasdaq.
International legal practice Osborne Clarke has advised Investec Bank plc, in its capacity as sponsor, on Medica Group plc’s £150m IPO.
Medica is the largest teleradiology provider by revenue in the UK, contracting with the largest pool of consultant radiologists outside of the NHS. The major selling shareholder, CBPE Capital LLP, sold the majority of its stake and retained approximately 11 per cent in the company which it acquired from Nuffield Health in May 2013.
Norton rose Fulbright has advised Goldman Sachs International and J.P. Morgan Cazenove, as global co-ordinators and bookrunners, on the IPO of BioPharma Credit PLC, a new UK investment trust which will be managed by Pharmakon Advisers, L.P., a New York based manager specialising in biopharma royalty investing and lending. This IPO is the largest in the UK this year.
April 03, 2017
NautaDutilh assisted Orion with secondary offering of shares
NautaDutilh Luxembourg assisted some of the selling shareholders of Orion Engineered Carbons S.A. (NYSE: OEC) (the “Company” or “Orion”) with the secondary offering of an aggregate 5,000,000 common shares of the Company by Kinove Luxembourg Holdings 1 S.à.r.l. (“Kinove Holdings”) and certain other sellers, including current and former members of Orion’s management team, in an underwritten public offering.
Gide has advised the Lead Manager BNP Paribas on Foncière des Murs’s share capital increase of around EUR 200 million with preferential subscription rights. The company’s main shareholders (Foncière des Régions, Predica, Generali Vie, Cardif Assurance Vie, ACM Vie and Pacifica) exercised the preferential subscription rights attached to their shares.